
Proposal for the Public Procurement Act, adoption of a new pharmaceutical legislation, and revision of pharmacovigilance practices should improve patient access to safe and innovative medicines in Europe.
This white paper demonstrates a vendor’s perspective on recent trends in regulations and the potential future direction for the industry.






